A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.

被引：1
|
作者：
Lim, Sung Hee
Yun, Jina
Lee, Min-Young
Kim, Han Jo
Kim, Kyoung Ha
Kim, Se Hyung
Lee, Sang-Cheol
Bae, Sang Byung
Kim, Chan Kyu
Lee, Namsu
Lee, Kyu Taek
Park, Sung Kyu
Hong, Dae Sik
Choi, Hyun Jong
Moon, Jong Ho
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Soonchunhyang Univ, Bucheon Hosp, Bucheon, South Korea
[3] Soonchunhyang Univ, Cheonan Hosp, Cheonan, South Korea
[4] Soonchunhyang Univ, Seoul Hosp, Seoul, South Korea
[5] Soon Chun Hyang Univ Hosp, Bucheon, Gyeongg, South Korea
[6] Soonchunhyang Univ, Hosp Seoul, Seoul, South Korea
[7] Soonchunhyang Univ, Seoul Hosp, Bucheon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
344
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Chul
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Seong Kyu
    Lee, Yun Nah
    Moon, Jong Ho
    YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 671 - 678
  • [2] A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer
    Yun, Jina
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Soong Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hoe Sook
    Choi, Hyun Jong
    Moon, Jong Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer
    Oh, D.
    Lee, K.
    Lee, K.
    Sohn, C.
    Zang, D.
    Ryoo, H.
    Song, H.
    Kim, J.
    Bang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Randomized phase II trial of panitumumab (P), erlotinib (E), and gemcitabine (G) versus erlotinib-gemcitabine in patients with untreated, metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Foster, N. R.
    Salim, M.
    Flynn, P. J.
    Moore, D. F., Jr.
    Zon, R.
    Mowat, R. B.
    McCullough, A.
    Meyers, J. P.
    Alberts, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [5] Randomized phase II trial of panitumumab, erlotinib, and gemcitabine (PGE) versus erlotinib-gemcitabine (GE) in patients with untreated, metastatic pancreatic adenocarcinoma.
    Kim, G. P.
    Foster, N. R.
    Salim, M.
    Flynn, P. J.
    Moore, D. F.
    Zon, R.
    Mowat, R. B.
    Wiesenfeld, M.
    McCullough, A. E.
    Alberts, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] A phase II randomized, placebo controlled study to evaluate the efficacy of the combination of gemcitabine, erlotinib, and metformin in patients with locally advanced or metastatic pancreatic cancer.
    Wilmink, Johanna
    Kordes, Sil
    Zwinderman, Koos
    Mathot, Ron
    Punt, Cornelis J. A.
    Richel, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [8] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [9] A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer.
    Kortmansky, JS
    O'Reilly, EM
    Minsky, BD
    Puleio, SA
    Winkelmann, J
    Kelsen, DP
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [10] Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer
    Khatri, P.
    Kumari, P.
    Beniwal, S.
    Samdariya, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 92 - 92
12345